These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25147732)

  • 1. Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma.
    Mansour AM; Arevalo JF; Al Kahtani E; Zegarra H; Abboud E; Anand R; Ahmadieh H; Sisk RA; Mirza S; Tuncer S; Navea Tejerina A; Mataix J; Ascaso FJ; Pulido JS; Guthoff R; Goebel W; Roh YJ; Banker AS; Gentile RC; Martinez IA; Morris R; Panday N; Min PJ; Mercé E; Lai TY; Massoud V; Ghazi NG
    J Ophthalmol; 2014; 2014():210458. PubMed ID: 25147732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of intravitreal injection of bevacizumab for choroidal neovascularization associated with choroidal osteoma.
    Yoshikawa T; Takahashi K
    Clin Ophthalmol; 2015; 9():429-37. PubMed ID: 25784788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FACTORS INFLUENCING NEED FOR RETREATMENT AND LONG-TERM VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Ng DS; Kwok AK; Tong JM; Chan CW; Li WW
    Retina; 2015 Dec; 35(12):2457-68. PubMed ID: 26035400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and antivascular endothelial growth factor effect of choroidal neovascularization in younger patients in Taiwan.
    Li YH; Cheng CK; Tseng YT
    Taiwan J Ophthalmol; 2015; 5(2):76-84. PubMed ID: 29018672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation.
    Singh SR; Fung AT; Fraser-Bell S; Lupidi M; Mohan S; Gabrielle PH; Zur D; Iglicki M; M López-Corell P; Gallego-Pinazo R; Farinha C; Lima LH; Mansour AM; Casella AM; Wu L; Silva R; Uwaydat SH; Govindahari V; Arevalo JF; Chhablani J
    Br J Ophthalmol; 2020 May; 104(5):678-683. PubMed ID: 31401554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myopic choroidal neovascularization treated by intravitreal bevacizumab: comparison of two different initial doses.
    Ruiz-Moreno JM; Montero JA; Amat-Peral P
    Graefes Arch Clin Exp Ophthalmol; 2011 Apr; 249(4):595-9. PubMed ID: 21234588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture.
    Barth T; Zeman F; Helbig H; Gamulescu MA
    BMC Ophthalmol; 2019 Nov; 19(1):239. PubMed ID: 31771544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization.
    Yoon JU; Kim YM; Lee SJ; Byun YJ; Koh HJ
    Retina; 2012 May; 32(5):949-55. PubMed ID: 22534553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab.
    Yang HS; Kim JG; Kim JT; Joe SG
    Am J Ophthalmol; 2013 Dec; 156(6):1201-1210.e2. PubMed ID: 24075429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-vascular endothelial growth factors for choroidal neovascularization secondary to choroidal osteoma: Long-term results.
    Lekha T; Renuka NS; Prasad HN
    Oman J Ophthalmol; 2015; 8(3):185-7. PubMed ID: 26903728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM; Lai TY; Liu DT; Lam DS
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Choroidal Neovascularizations in Choroidal Osteoma Treated with Anti-VEGF Injections: A 6-Year Follow-Up Case Report.
    Xuan Y; Wang M
    Retin Cases Brief Rep; 2024 Mar; ():. PubMed ID: 38442419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal Anti-vascular Endothelial Growth Factor for Treating Polypoidal Choroidal Vasculopathy with Grape-like Polyp Clusters.
    Chang YS; Kim JH; Kim JW; Lee TG; Kim CG
    Korean J Ophthalmol; 2016 Aug; 30(4):272-9. PubMed ID: 27478354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANTIANGIOGENICS IN CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH LASER IN CENTRAL SEROUS CHORIORETINOPATHY.
    Chhablani J; Pichi F; Silva R; Casella AM; Murthy H; Banker A; Nowilaty SR; Carrai P; Nucci P; Arevalo JF;
    Retina; 2016 May; 36(5):901-8. PubMed ID: 27115855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal Bevacizumab for Nonsubfoveal Choroidal Neovascularization Associated With Angioid Streaks: 3-Year Follow-up Study.
    Iacono P; Battaglia Parodi M; La Spina C; Bandello F
    Am J Ophthalmol; 2016 May; 165():174-8. PubMed ID: 27013066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of choroidal neovascularization complicating a choroidal osteoma with intravitreal bevacizumab.
    Rao S; Gentile RC
    Retin Cases Brief Rep; 2010; 4(4):303-5. PubMed ID: 25390904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma.
    Wu ZH; Wong MY; Lai TY
    Case Rep Ophthalmol; 2012 May; 3(2):200-4. PubMed ID: 22740831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization.
    Lai TY; Luk FO; Lee GK; Lam DS
    Eye (Lond); 2012 Jul; 26(7):1004-11. PubMed ID: 22595908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal ranibizumab for the treatment of pathological myopia associated with choroidal neovascularization in Chinese patients.
    Yang X; Dai H
    Chin Med J (Engl); 2014; 127(16):2906-10. PubMed ID: 25131225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization.
    Ahn SJ; Park KH; Woo SJ
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5794-800. PubMed ID: 26325418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.